Drug Profile
SIG 1322
Alternative Names: SIG-1322Latest Information Update: 19 Sep 2023
Price :
$50
*
At a glance
- Originator Signum Dermalogix
- Class Small molecules; Terpenes
- Mechanism of Action G protein-coupled receptor modulators; Signal transduction pathway modulators; Toll-like receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Atopic dermatitis
Most Recent Events
- 19 Sep 2023 Discontinued - Preclinical for Atopic dermatitis in USA (Topical) (Signum Dermalogix website, September 2023)
- 28 Sep 2020 No recent reports of development identified for preclinical development in Atopic-dermatitis in USA (Topical)
- 11 Aug 2016 Preclinical trials in Atopic dermatitis in USA (Topical)